@article{ref1,
title="Recombinant snake antivenoms get closer to the clinic",
journal="Trends in immunology",
year="2024",
author="Laustsen, Andreas H.",
volume="ePub",
number="ePub",
pages="ePub-ePub",
abstract="Snakebite envenomings kill ~100 000 victims each year and leave many more with permanent sequelae. Antivenoms have been available for more than 125 years but are in need of innovation. A new study by Khalek et al. highlights broadly neutralizing human monoclonal antibodies (mAbs) that might be used to develop recombinant antivenoms with superior therapeutic benefits.<p /> <p>Language: en</p>",
language="en",
issn="1471-4906",
doi="10.1016/j.it.2024.03.001",
url="http://dx.doi.org/10.1016/j.it.2024.03.001"
}